For instance, CCL20, CCL17, and CCL22 have been described to recruit Treg cells in the TEMs of non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and muscle-invasive bladder cancer (MIBC) [87]. Here, CCL22 is linked to non-small cell lung carcinoma.